NEWSWIRETODAY Press Release & Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Agency / Source: Persistence Market Research (P) Ltd

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Australia Nitric Acid Market Expected to Reach at Value of $1.3B by 2024 End Says PMR - According to a report by Persistence Market Research (PMR), the Australia nitric acid market, which was valued at $725.3 million in 2016 is anticipated to grow 1.8X, reaching $1.3 billion by 2024-end
Australia Nitric Acid Market Expected to Reach at Value of $1.3B by 2024 End Says PMR

 

NewswireTODAY - /newswire/ - New York, NY, United States, 2017/06/28 - According to a report by Persistence Market Research (PMR), the Australia nitric acid market, which was valued at $725.3 million in 2016 is anticipated to grow 1.8X, reaching $1.3 billion by 2024-end.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

In terms of volume share, market is expected to increase at 7.8% CAGR during 2016-2024. The report by PMR titled ‘Australia Nitric Acid Market: Industry Analysis and Forecast, 2016-2024’, provides an in-depth analysis on the performance of Australian nitric acid market, along with important trends and factors influencing the market.

Growing mining activities and expansion in capacity of facilities of ammonium nitrate are the factors expected to fuel the growth of nitric acid market in Australia during 2016-2024. An increase in demand for ammonium nitrate explosives has resulted in an increase in production of ammonium nitrate. This is expected to fuel demand for nitric acid during 2016-2024.

Due to the high dependency of ammonium nitrate explosives on mining exploration activities, the increase in mining exploration activities in Australia, especially in Queensland and Western Australia is set to witness growth in the production as well as consumption in the country. However, the rise in alternatives being developed for ammonium nitric-based explosives could hamper the growth of Australian nitric acid market.
In terms of application of nitric acid, the explosives accounted for volume share of 90% in 2015. However, registering 8.0% CAGR during the forecast period, explosives is expected to influence the Australian nitric acid market. Non-fuming product is expected to have largest share in nitric acid market in the country, registering 8.2% CAGR during 2016-2024. This will also create an opportunity of $580.4 million in the region.

The market value of non-fuming product is expected to rise to $1.24 billion by 2024-end from $609.7 million in 2015. Fuming nitric acid applied in litho printing and precious metal refining is anticipated to act as a driving force in growth of fuming segment, by application. In 2015, in terms of value, commercial grade accounted for 95.3% market share of nitric acid in Australia. Commercial grade is expected to expand at 7.9% CAGR between 2016 and 2024. In 2015, by application of nitric acid, explosives accounted for 95.4% Australia nitric acid market share on basis of value. The explosives market share in terms of value is expected to register 8.0% CAGR during 2016-2024.

Region-wise, the report has segmented Australia nitric acid market into Queensland, New South Wales, Western Australia, Victoria and rest of Australia. Among all these regions, Western Australia and Queensland are considered to be the largest market in Australia for nitric acid. In 2015, both the regions together accounted for 58.0% market share. According to the report, during 2016-2024, Queensland, Western Australia and New South Wales will be considered as the most attractive markets in Australia for nitric acid. Nitric acid consumption in all these three regions together was projected to reach 1,444.9 kilotons in 2016 end.

The report has also profiled some of the leading players in nitric acid market in Australia such as Energy & Fertilizers, Orica Limited, Incitec Pivot Limited and Wesfarmers Chemicals.

About Persistence Market Research (PMR)

Persistence Market Research (persistencemarketresearch.com) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Persistence Market Research (P) Ltd

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Australia Nitric Acid Market Expected to Reach at Value of $1.3B by 2024 End Says PMR

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Rahul Singh - PersistenceMarketResearch.com 
646-568-7751 sales[.]persistencemarketresearch.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Persistence Market Research (P) Ltd securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Persistence Market Research (P) Ltd / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

Ono Pharma Announces an Exclusive License Agreement with Biohaven to Develop and Commercialize IgG Degraders in Japan, South Korea, Taiwan, and ASEAN
Ono Received Manufacturing and Marketing Approval in Japan for XCOPRI® Tablets for the Treatment of Patients with Partial-onset Seizures
Molecular Devices and STEMCELL Technologies Collaborate to Accelerate Adoption of Human-Relevant Organoid Models through Automation
ZAGENO Earns Frost & Sullivan’s 2026 North American Life Sciences E‑Commerce Company of the Year Recognition
SCHOTT Pharma, Takeda and Corplex Bring Closed-loop Recycling System for Pharmaceutical Vial Trays into Operations
Ono Pharma Enters into a Drug Discovery Partnership with Aitia in Neurological Diseases
STEMCELL Technologies Joins BLOODPAC to Advance Pre-Analytical Best Practices for Liquid Biopsy
OPDIVO® Intravenous Infusion Approved in Taiwan for the Treatment of Resectable Non-Small Cell Lung Cancer
Ono Pharma Enters into a Drug Discovery Partnership with Mediar Therapeutics to Create Novel Antibody Therapeutics for Fibro-inflammatory Diseases
OPDIVO® Intravenous Infusion Approved in South Korea for the Treatment of Resectable Non-Small Cell Lung Cancer
Ipsen Completes Acquisition of Memo Therapeutics AG, Adding First-in-class Asset to Ipsen’s Rare Disease Pipeline
SCHOTT Pharma and Nemera Deliver Verified Pen Injector Platform with Sterile Cartridge System
IQIRVO® Demonstrates Statistically Significant Improvement in ALP Normalization in Patients with PBC in Phase IIIb ELSPIRE Study
Dysport® is the First Botulinum Toxin to Achieve Positive Topline Phase III Results in Both Episodic and Chronic Migraine
STEMCELL Technologies and CCRM Partner to Expand Access to Matched GMP and RUO iPSC Lines for Cell Therapy Development

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Limelon Advertising, Co.

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2005-2026 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS | 
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)